丽珠医药(01513.HK)8月13日耗资404万元回购10.15万股A股

Group 1 - The company, Lijun Pharmaceutical (01513.HK), announced a share buyback plan, intending to repurchase 101,500 A-shares at a cost of 4.04 million RMB [1] - The buyback is scheduled to take place on August 13, 2025 [1] - This move indicates the company's strategy to enhance shareholder value through share repurchase [1]